Physician profile
Andrew Egan
NPI 1134652878
$16,846.91
in general payments reported to CMS, 2019-2025
47 companies · $3,837 in 2025
The $3,837 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $782 · 2021: $2,970 · 2022: $2,693 · 2023: $3,181 · 2024: $3,384 · 2025: $3,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $70.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,331.28 |
| Education | $70.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,280.98 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,711.32 | 2020-2025 | Ubrelvy, Qulipta, Linzess |
| Pfizer INC. | $1,619.67 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,328.13 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $1,272.80 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $917.39 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Astellas Pharma US INC | $822.53 | 2020-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $690.82 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $638.74 | 2020-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $493.01 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $336.50 | 2020-2025 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.71 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Amarin Pharma, INC. | $318.83 | 2020-2022 | |
| Dexcom, INC. | $288.37 | 2021-2025 | Dexcom G6 Transmitter |
| Lundbeck LLC | $279.72 | 2024-2025 | Rexulti |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $277.60 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $274.27 | 2024-2025 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $267.81 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $254.52 | 2020-2025 | Gardasil 9, Capvaxive, Vaqta |
| Janssen Pharmaceuticals, INC | $251.20 | 2021-2024 | Xarelto |
| Biohaven Pharmaceutical Holding Company LTD. | $232.66 | 2022 | |
| Abiomed | $201.36 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $201.13 | 2021-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $190.69 | 2020-2025 | Nexletol |
| Phathom Pharmaceuticals, INC. | $157.83 | 2023-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $157.01 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $136.68 | 2020-2025 | Seglentis, Zoryve |
| Aimmune Therapeutics, INC. | $122.25 | 2024-2025 | Zenpep |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $115.29 | 2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.88 | 2023-2025 | Xifaxan, Trulance |
| Teva Pharmaceuticals USA, INC. | $60.45 | 2020-2023 | Airduo Digihaler |
| Pulmonx Corporation | $53.06 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Dynavax Technologies Corporation | $52.03 | 2024 | Heplisav-B |
| Takeda Pharmaceuticals U.S.A., INC. | $49.70 | 2020-2025 | Eohilia |
| Ultragenyx Pharmaceutical INC. | $44.80 | 2021 | |
| Sanofi Pasteur INC. | $43.99 | 2023-2025 | |
| Almatica Pharma LLC | $43.53 | 2021-2025 | Loreev Xr |
| Azurity Pharmaceuticals, INC. | $36.94 | 2024 | Edarbi |
| Amneal Pharmaceuticals LLC | $36.70 | 2022-2024 | Unithroid |
| Inspire Medical Systems, INC. | $33.88 | 2024 | Inspire |
| Eisai INC. | $29.25 | 2021 | |
| Lifescan, INC. | $24.63 | 2023 | |
| Si-Bone, INC. | $19.69 | 2024 | |
| Collegium Pharmaceutical, INC. | $19.66 | 2024 | Xtampza |
| Xeris Pharmaceuticals, INC. | $19.28 | 2024 | Gvoke Hypopen |
| Phadia US INC. | $14.70 | 2023 | Immunocap |
| Horizon Therapeutics Plc | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Egan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.